Aeglea BioTherapeutics, Inc., (NASDAQ: AGLE) a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE